To clarify the mechanism of epigenetic modification in regulating PDK1 in breast cancer, we address following questions: Firstly, to explore whether PDK1 expression is dysregulated in breast cancer and the aberrant expression of PDK1 is regulated by histone deacetylase 2 (HDAC2) and EZH2. This evidence concerns the gene EZH2 and breast cancer.